Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
02/18/2004 | CN1476322A Use of cyclosporin A7-thioamide derivatives for hair growth |
02/18/2004 | CN1476318A O/W emulsion composition and method of preparing same |
02/18/2004 | CN1475765A Grouping drying device for preparing Chinese and western medicine pill, pellet and its technology |
02/18/2004 | CN1475275A Mannan peptide freeze dried powder ampoule for injection |
02/18/2004 | CN1475269A Rhizoma cimicifugae extract and its preparation method |
02/18/2004 | CN1475267A Sanshe wind-dispelling plaster |
02/18/2004 | CN1475266A Production method of injection agent used for treating cardio and cerebro vascular diseases and its product |
02/18/2004 | CN1475262A Medicine for treating asynodia and prospermia |
02/18/2004 | CN1475261A Medicine for treating gastral cavity pain and its preparation method |
02/18/2004 | CN1475259A Compound ganmaoling tablet (film coating tablet for treating common cold) and its manufacturing method |
02/18/2004 | CN1475258A Compound dantong tablet (film coating tablet for disorder of gallbladder) and its manufacturing method |
02/18/2004 | CN1475257A Medicinal plaster for treating chololithiasis |
02/18/2004 | CN1475256A Medicinal plaster for treating urolithiasis |
02/18/2004 | CN1475255A Medicinal plaster for treating algomenorrhea and regulating menstrual function |
02/18/2004 | CN1475254A Medicine for treating coronary disease and stenocardia and its preparation method |
02/18/2004 | CN1475253A Quick effect toothache plaster |
02/18/2004 | CN1475242A Preparation method of ginkgo leaf extract freeze dried powder injection |
02/18/2004 | CN1475239A Chinese herbal medicine plaster and its processing technology |
02/18/2004 | CN1475226A Application of nano copper powder in preparation of antisenility medicine |
02/18/2004 | CN1475225A Use of Bacille Calmette-Guerin polysaccharide nucleic acid in the preparation of medicine for oral cavity local administration |
02/18/2004 | CN1475222A Vine leaf extract and its preparation process |
02/18/2004 | CN1475221A Luerythromycin oculentum |
02/18/2004 | CN1475219A Medicinal composition for treating blood vessel disease |
02/18/2004 | CN1475216A Egg yolk lecithin soft capsule and its production process |
02/18/2004 | CN1475215A Enosaxin for injection and its preparation method |
02/18/2004 | CN1475213A Soyisoflavone soft capsule and its preparation technology |
02/18/2004 | CN1475209A Slow-released agent form of sertraline |
02/18/2004 | CN1475208A Slow-released agent form of sertraline |
02/18/2004 | CN1475207A Solid oral dosage mode containing walshaden and hydrochloric thizaine |
02/18/2004 | CN1475206A Medical composition containing micropowdery bicyclic medicine |
02/18/2004 | CN1475205A Medicine conveying system--preparation method of solid nano medicine |
02/18/2004 | CN1475204A Medicinal Composition, dry powder vapor, nebula, nebula auxiliary preparation for use through mouth and nose and its preparation method |
02/18/2004 | CN1475203A Coloured plaster and its preparation method |
02/18/2004 | CN1138591C Coated particles, method of making and using |
02/18/2004 | CN1138579C Diffusional implantable delivery system |
02/18/2004 | CN1138561C Chewing gum for preventing decayed tooth and its preparing process |
02/18/2004 | CN1138559C Pill medicine for treating cardio-cerebro vascular diseases |
02/18/2004 | CN1138552C Polyphenol extract of tea, use thereof and formulations containing same |
02/18/2004 | CN1138550C Process of producing extracts of shark |
02/18/2004 | CN1138547C Hormonal medicaments for correcting oestrogen deficiencies |
02/18/2004 | CN1138543C Lyophilizate of lipid complex of water insoluble camptothecins |
02/18/2004 | CN1138542C Method for stabilizing pharmaceutical composition by special use of antioxidant |
02/18/2004 | CN1138541C Pharmaceutically stable oxaliplatinum prepn. |
02/18/2004 | CN1138537C Probucol clathrate capsule and its prepn. process |
02/18/2004 | CN1138536C Oil/water fat emulsion or its application of freeze dry composition |
02/18/2004 | CN1138535C Pharmaceutical compositions contg. effervescent acid -base couple |
02/18/2004 | CN1138534C Multiple unit tableted dosage |
02/18/2004 | CN1138533C Liposomes |
02/18/2004 | CN1138532C Pharmaceutical aerosol composition |
02/18/2004 | CN1138531C Dispersible macromolecule compositions and method for their preparation and use |
02/18/2004 | CN1138530C Liquid ophthalmic sustained release delivery system |
02/18/2004 | CN1138529C Fizzy formulation |
02/18/2004 | CN1138528C Peptide/protein suspension temper |
02/18/2004 | CN1138527C Osmotic device with delayed activation of drug delivery and complete drug release |
02/18/2004 | CN1138526C Intravaginal drug delivery devices for administration of 17 beta-oestradiol precursors |
02/18/2004 | CN1138519C Nano-emulsion contaning alkoxyalkenyl or glucose alkoxyalkenyl succinate and uses in cosmetics and pharmaceutics |
02/18/2004 | CN1138505C Anti-angiogenic compositions and method of use |
02/17/2004 | US6694191 Ambulatory medical apparatus and method having telemetry modifiable control software |
02/17/2004 | US6693208 Amino acids which deliver active agents to selected biological systems in increased or improved bioavailability |
02/17/2004 | US6693135 Prostaglandin compositions and methods of treatment for male erectile dysfunction |
02/17/2004 | US6693129 A biochemical formulation comprising ascorbic acid, niacin, lysine, and proline useful for lowering plasma concentration of a lipoprotein in mammal |
02/17/2004 | US6693099 Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
02/17/2004 | US6693096 Treatment of inflammation-associated disorders using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors |
02/17/2004 | US6693086 Eliciting nonantigen and strong antigen specific immune response; cancer, allergic inflammation and/or infectious disease prevention |
02/17/2004 | US6692775 Bactericidal gel and method for treating burns and dermal lesions |
02/17/2004 | US6692773 Treatment of hyperproliferative skin disorders and diseases |
02/17/2004 | US6692771 Emulsions as solid dosage forms for oral administration |
02/17/2004 | US6692770 Suitable for parenteral administration, preferably via injection comprising amylopectin |
02/17/2004 | US6692769 Drug-containing core coated with a mixture of a hydrophobic organic compound-water-insoluble polymer, which prevents sticking during compression molding when producing oral sustained release tablets |
02/17/2004 | US6692768 Spherical fine particles that are useful in the production of easily-swallowed, controlled-release preparations having a mean particle size of 60-200 mu m |
02/17/2004 | US6692767 Solid solution beadlet |
02/17/2004 | US6692766 For increasing the bioavailability of orally administered drugs belonging to the following categories: large molecular weight drugs, drugs that lose their potency in the gastrointestinal tract as a result of enzymatic degradation |
02/17/2004 | US6692765 Exactly divisible tablet |
02/17/2004 | US6692764 Treatment and prevention of diseases involving bone resorption, especially osteoporosis, paget's disease, malignant hypercalcemia, and metastatic bone disease; binder-free tablets |
02/17/2004 | US6692763 Equivalent to a serum estadiol level not exceeding of between about 5 pg/ml and about 15 pg/ml, for treatment of physical conditions associated with menopause: hot flashes; bone loss; headache; nausea etc. |
02/17/2004 | US6692762 Generating linoleic acid derivatives; obtain chemical intermediates, incubate with lipase, recover fatty acid conjugated to linoleic acid |
02/17/2004 | US6692759 Dissolving biocompatible polymer in suitable solvent solution, adding chemical substance, drying mixture, refrigerating dry mass |
02/17/2004 | US6692755 Emulsifier-free finely disperse systems of the oil-in-water and water-in-oil type |
02/17/2004 | US6692734 N,O-amidomalonate platinum complexes |
02/17/2004 | US6692695 Vacuum drying solution or suspension by mixing to boiling without freezing; heat exchanging; monitoring; storage stable viruses and cells |
02/17/2004 | US6692457 Flow condition sensor assembly for patient infusion device |
02/17/2004 | US6691457 Floral packaging material having great masters prints thereon |
02/17/2004 | CA2408585C Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals |
02/17/2004 | CA2290969C Delayed-release dosage forms of sertraline |
02/17/2004 | CA2268908C Pharmaceutical and cosmetic antiacne formulations containing plant extracts (krameria triandra or mesua ferrea) |
02/17/2004 | CA2183755C Pharmaceutical preparation containing plasminogen activators |
02/17/2004 | CA2145505C Microparticle preparations made from biodegradable copolymers |
02/17/2004 | CA2074348C Stable compositions for parenteral administration and their use |
02/14/2004 | CA2454644A1 Cannabinoid liquid formulations for mucosal administration |
02/13/2004 | CA2437064A1 Storage-stable, liquid fibrinogen formulation |
02/13/2004 | CA2395819A1 Dual-spike release formulation for oral drug delivery |
02/12/2004 | WO2004013605A2 Nanoparticles comprising a mixed monolayer for specific ligand binding |
02/12/2004 | WO2004013310A2 Methods of down regulating target gene expression in vivo by introduction of interfering rna |
02/12/2004 | WO2004012855A2 Ethylene glycol monolayer protected nanoparticles |
02/12/2004 | WO2004012795A2 Methods of delivering therapeutic agents |
02/12/2004 | WO2004012791A2 Improved injection system |
02/12/2004 | WO2004012772A1 Oral administration of calcitonin |
02/12/2004 | WO2004012771A1 Pharmaceutical compositions comprising cyclosporin for oral administration |
02/12/2004 | WO2004012770A1 Oral pharmaceutical compositions comprising cyclosporin |
02/12/2004 | WO2004012751A1 Bacterial cell wall skeleton component preparaion |